Patent · US Active

7-azaindole-2,7-naphthyridine derivative for the treatment of tumours

US9382244B2 · kind B2 · utility

1Cited by

1References

8Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Alfred Jonczyk · Darmstadt, DE
Frank Zenke · Darmstadt, DE
Christiane Amendt · Mühltal, DE

Key dates

Filing date	Sep 9, 2013
Grant date	Jul 5, 2016
Priority date	—
Expiry date	Sep 9, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The compound 4-(2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-2,7-naphthyridin-1-ylamine and pharmaceutically usable salts and/or tautomers thereof. The use of this compound for the treatment of tumors, tumor growth, tumor metastases and/or AIDS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.